This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Following on its acquisition of 454 Life Sciences a few months ago, Roche this week signed a definitive agreement to acquire privately held microarray firm NimbleGen Systems for $272.5 million, which is 20 times NimbleGen’s 2006 revenues.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.